Skip to main content

Table 1 Characters of reported cases of IVNKL

From: Intravascular NK-cell lymphoma: a case report and review of the literature

Case number/case

Age/gender

Involved organ(s)

Treatment and follow up

1. Santucci et al. [1]

54/M

Skin, CNS

Chemotherapy, died 17 months after diagnosis

2. Wu et al. [5]

41/M

Skin

Chemotherapy, alive and event free at 12 months

3. Wu et al. [5]

47/F

CNS, bone marrow, kidneys, ovaries, cervix

Treatment unclear, died half a month after diagnosis

4. Kuo et al.[6]

71/F

Skin

Alive 5 months after diagnosis without treatment

5. Song et al. [7]

40/F

Skin

Chemotherapy, alive and event free at 7 months

6. Nakamichi et al.[8]

23/F

Skin

Chemotherapy and stem cell transplantation, died of acute GVHD 9 months after diagnosis

7. Cerroni et al. [9]

63/M

Skin

Chemotherapy, died 6 months after diagnosis

8. Liao et al. [10]

42/F

Skin

Chemotherapy and radiotherapy, alive with disease 14 months after diagnosis

9. Gebauer et al.[11]

72/M

Skin, bone marrow, CNS

Chemotherapy, died 7 months after diagnosis

10. Liu et al. [12]

37/F

Skin, CNS

Chemotherapy, died 13 months after diagnosis

11.our case

29/M

Skin, liver

Chemotherapy, died 3 months after diagnosis

Case number/case

Immunophenotypes

PCR-TCR

CD3

CD4

CD5

CD8

CD20

CD30

CD56

Cytotoxic markers

EBER

1. Santucci et al. [1]

+

-

NA

-

-

+

+

+

+

ND

2. Wu et al. [5]

+

-

-

-

-

-

+

+

+

P

3. Wu et al. [5]

+

-

-

-

-

NA

+

+

-

P

4. Kuo et al. [6]

+

-

-

-

-

-

+

+

+

P

5. Song et al. [7]

+

-

NA

-

-

NA

+

+

+

P

6. Nakamichi et al.[8]

+

NA

NA

NA

-

NA

+

+

+

ND

7. Cerroni et al. [9]

+

-

NA

-

-

NA

+

+

+

P

8. Liao et al.[10]

+

-

-

-

-

-

+

+

+

ND

9. Gebauer et al.[11]

+

-

NA

-

-

-

+

+

+

P

10. Liu et al. [12]

+

-

-

-

-

-

+

+

+

ND

11.our case

+

-

-

-

-

+

+

+

+

P

  1. M, male; F, female
  2. GVHD, graft-versus-host disease
  3. NA, not available
  4. cytotoxic markers, TIA-1 and/or granzyme B and/or perforin
  5. PCR-TCR, polymerase chain reaction analysis of the T-cell receptor g gene
  6. P, polyclonal smear